Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Who knew what, and when did they first know it.
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Re: Institutional Ownership.

My info on ownership is supported by Reuters: Institutions own 0.0% of the 0.41 billion common shares outstanding.

Reuters is technically correct, even if your data is also technically correct. The ownership you posted totals something less than 0.03% of the shares. Rounding gives you 0.0% (Reuters number). This is typical of the accuracy in financial summaries - nobody wants to talk about the pennies.

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply